Zobrazeno 1 - 10
of 410
pro vyhledávání: '"Ponzone, P"'
Autor:
Luca Ponzone, Valentina Audrito, Claudia Landi, Enrico Moiso, Chiara Levra Levron, Sara Ferrua, Aurora Savino, Nicoletta Vitale, Massimiliano Gasparrini, Lidia Avalle, Lorenza Vantaggiato, Enxhi Shaba, Beatrice Tassone, Stefania Saoncella, Francesca Orso, Daniele Viavattene, Eleonora Marina, Irene Fiorilla, Giulia Burrone, Youssef Abili, Fiorella Altruda, Luca Bini, Silvia Deaglio, Paola Defilippi, Alessio Menga, Valeria Poli, Paolo Ettore Porporato, Paolo Provero, Nadia Raffaelli, Chiara Riganti, Daniela Taverna, Federica Cavallo, Enzo Calautti
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Background The main drawback of BRAF/MEK inhibitors (BRAF/MEKi)-based targeted therapy in the management of BRAF-mutated cutaneous metastatic melanoma (MM) is the development of therapeutic resistance. We aimed to assess in this context the
Externí odkaz:
https://doaj.org/article/18874da7221f495c92ee85e23df7d535
Autor:
Valentina E. Bounous, Carola Minella, Luca Fuso, Silvia Actis, Greta Petroni, Luca G. Sgrò, Martina Borghese, Nicoletta Tomasi Cont, Riccardo Ponzone, Annamaria Ferrero
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 2305-2315 (2024)
Background: pregnancy-associated breast cancer (PABC) affects one in 3000 pregnancies, often presenting with aggressive features. Methods: We retrospectively evaluated a cohort of 282 young BC patients (≤45 years old) treated between 1995 and 2019,
Externí odkaz:
https://doaj.org/article/bcbe79fc168a4fcabe84a4456b6ea690
Autor:
Francesca Accomasso, Silvia Actis, Carola Minella, Roberta Rosso, Claudia Granaglia, Riccardo Ponzone, Nicoletta Biglia, Valentina Elisabetta Bounous
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9860-9871 (2023)
Male breast cancer (BC) represents less than 1% of male tumors. Little is known about male BC characteristics, management, and survival, with many studies based on a small number of cases. Consequently, the treatment of male BC lacks specific guideli
Externí odkaz:
https://doaj.org/article/afef764f7a0441e38e7dc82d58eb1f90
Autor:
Roberto Ruiu, Chiara Cossu, Antonella Iacoviello, Laura Conti, Elisabetta Bolli, Luca Ponzone, Jolanda Magri, Alekya Rumandla, Enzo Calautti, Federica Cavallo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-16 (2023)
Abstract Background The upregulation of antioxidant mechanisms is a common occurrence in cancer cells, as they strive to maintain balanced redox state and prevent oxidative damage. This includes the upregulation of the cystine/glutamate antiporter xC
Externí odkaz:
https://doaj.org/article/13f8c99deeec400184da758ebeb3e721
Publikováno v:
Journal of Marine Science and Engineering, Vol 12, Iss 6, p 978 (2024)
A review of the prey of three amphiatlantic dolphin species, Tursiops truncatus, Stenella coeruleoalba and Delphinus delphis, is carried out. The main objective of this work is to review the feeding of these species in the Atlantic in order to assess
Externí odkaz:
https://doaj.org/article/cfdc56c501644c6181d6bcf4c4e44808
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Enrico Berrino, Laura Annaratone, Sara Erika Bellomo, Giulio Ferrero, Amedeo Gagliardi, Alberto Bragoni, Dora Grassini, Simonetta Guarrera, Caterina Parlato, Laura Casorzo, Mara Panero, Ivana Sarotto, Silvia Giordano, Matteo Cereda, Filippo Montemurro, Riccardo Ponzone, Nicola Crosetto, Alessio Naccarati, Anna Sapino, Caterina Marchiò
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-16 (2022)
Abstract Background The “HER2-low” nomenclature identifies breast carcinomas (BCs) displaying a HER2 score of 1+/2+ in immunohistochemistry and lacking ERBB2 amplification. Whether HER2-low BCs (HLBCs) constitute a distinct entity is debated. Met
Externí odkaz:
https://doaj.org/article/bd792d56b3094029b4da87b8d57caeff
Autor:
F. Accomasso, S. Actis, C. Minella, R. Rosso, M. D’Alonzo, R. Ponzone, V.E. Bounous, N. Biglia
Publikováno v:
Breast, Vol 68, Iss , Pp S72- (2023)
Externí odkaz:
https://doaj.org/article/4bdc772b53c743deaae31431b64a17c6